TRPV1 and diabetic neuropathy: Our second hypothesis is that restoration of CGRP, via chronic activation of TRPV1 by dietary capsaicin, genetic modulatory and pharmacological approaches, would limit the abnormality of intracellular ROS and the mitochondrial transmembrane potentials, and improve the impairment of the peripheral nerves in the development of diabetic neuropathy.